Aurora Cannabis (ACB) Return on Capital Employed (2020 - 2025)
Aurora Cannabis (ACB) reported Return on Capital Employed of 1.35% for Q1 2025, up 1523.0% year-over-year from 0.08% in Q1 2024, and up 109.74% quarter-over-quarter from 13.88% in Q1 2024.
Aurora Cannabis (ACB) Return on Capital Employed (2020 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has 5 years of Return on Capital Employed data on file, last reported at 1.35% in Q1 2025.
- Return on Capital Employed for Q1 2025 came in at 1.35%, up 1523.0% year-over-year; the trailing twelve-month figure through Mar 2025 was 1.35% (up 1523.0% YoY), and the FY2025 annual result was 0.65%, up 698.0% from the prior year.
- Return on Capital Employed rose to 1.35% in Q1 2025 per ACB's latest filing, from 13.88% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 1.35% in Q1 2025 and troughed at 13.88% in Q1 2024.
- A 4-year average of 8.6% and a median of 10.93% in 2021 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2021 and 2022: Return on Capital Employed soared 1857 bps in 2021, then tumbled 58 bps in 2022.
- A 4-year view of Return on Capital Employed shows it stood at 10.64% in 2021, then retreated by 5 bps to 11.22% in 2022, then dropped by 24 bps to 13.88% in 2024, then jumped by 110 bps to 1.35% in 2025.
- Business Quant data shows ACB's Return on Capital Employed at 1.35% in Q1 2025, 13.88% in Q1 2024, and 11.22% in Q2 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 8.52% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 27.58% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 21.43% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 20.04% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 7.34% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 6.92% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 14.85% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -1.92% |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 21.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 1.35% |
| Mar 31, 2024 | -13.88% |
| Jun 30, 2022 | -11.22% |
| Jun 30, 2021 | -10.64% |
| Jun 30, 2020 | -29.22% |